Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

This phase 1, open‐label, dose‐escalation study investigated the tolerated dose (recommended dose), safety, efficacy, and pharmacokinetics of pomalidomide alone or pomalidomide plus low‐dose dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma. Twelve patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Matsue, Kosei, Iwasaki, Hiromi, Chou, Takaaki, Tobinai, Kensei, Sunami, Kazutaka, Ogawa, Yoshiaki, Kurihara, Mari, Midorikawa, Shuichi, Zaki, Mohamed, Doerr, Thomas, Iida, Shinsuke
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2015
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714698/
https://ncbi.nlm.nih.gov/pubmed/26292221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12772
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi